Tariff

While some companies have already made forward movement in planning to build new facilities in the US, such as Roche and Novartis from Switzerland, to evade these tariffs, Alex Schriver, senior vice president for Pharmaceutical Research and Manufacturers of America (PhRMA), said in a statement that he’s worried about how this will impact the industry. “Every dollar spent on tariffs is…